HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Withdrawals: FDA, GAO Differ On Whether Recent Increase Is “Real”

Executive Summary

The prescription drug withdrawal rate has not shown a "real" increase since the implementation of the Prescription Drug User Fee Act, FDA declared in response to a Government Accounting Office report
Advertisement

Related Content

Rx Approval Times Depend On Amount, Not Source, Of FDA Funds, Study Says
Rx Approval Times Depend On Amount, Not Source, Of FDA Funds, Study Says
FDA Generic Biologics Policy May Be One Change Under McClellan
FDA Generic Biologics Policy May Be One Change Under McClellan
CDER/CBER Consolidation: Drug Center Structure Is Not Expected To Change
PDUFA III Implementation Begins: FDA Working Groups Under Way
PDUFA III Implementation Begins: FDA Working Groups Under Way
Advertisement
UsernamePublicRestriction

Register

PS040556

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel